
Liquidia Corporation LQDA
$ 54.39
-4.09%
Liquidia Corporation Historical Prices | LQDA
Annual Historical Prices Liquidia Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 34.2 | 34.2 | 14.7 | 7.22 | 4.87 | 2.95 | 4.28 | 21.7 | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 34.2 | 2.95 | 15.5 |
Historical Prices of other stocks in the Biotechnology industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Vanda Pharmaceuticals
VNDA
|
6.07 | $ 3.44 | -6.27 % | $ 203 M | ||
|
VistaGen Therapeutics
VTGN
|
0.57 | $ 0.16 | -12.33 % | $ 6.09 M | ||
|
Voyager Therapeutics
VYGR
|
4.11 | $ 1.52 | -5.9 % | $ 89.2 M | ||
|
Verrica Pharmaceuticals
VRCA
|
6.26 | $ 2.74 | -5.03 % | $ 29.2 M | ||
|
Wave Life Sciences Ltd.
WVE
|
15.4 | $ 2.56 | -6.07 % | $ 432 M | ||
|
XBiotech
XBIT
|
2.31 | $ 1.75 | 4.17 % | $ 53.4 M | ||
|
XTL Biopharmaceuticals Ltd.
XTLB
|
1.27 | $ 1.37 | -7.43 % | $ 922 M | ||
|
Adial Pharmaceuticals
ADIL
|
1.96 | $ 3.15 | -35.42 % | $ 2.11 M | ||
|
ADMA Biologics
ADMA
|
15.9 | $ 13.18 | -1.2 % | $ 3.14 B | ||
|
Exicure
XCUR
|
4.61 | $ 0.96 | -7.24 % | $ 6.05 M | ||
|
Xencor
XNCR
|
12 | $ 33.48 | -1.56 % | $ 2.49 B | ||
|
Cortexyme
CRTX
|
1.88 | - | -1.05 % | $ 67.1 M | ||
|
Burford Capital Limited
BUR
|
12.7 | $ 3.24 | -5.55 % | $ 710 M | ||
|
Daré Bioscience
DARE
|
1.51 | $ 0.41 | -9.93 % | $ 4.58 M | ||
|
Fate Therapeutics
FATE
|
1.57 | $ 0.92 | -9.07 % | $ 109 M | ||
|
Greenwich LifeSciences
GLSI
|
28.5 | $ 19.09 | -3.54 % | $ 258 M | ||
|
Halozyme Therapeutics
HALO
|
80.6 | $ 91.28 | -1.89 % | $ 10.9 B | ||
|
Hutchison China MediTech Limited
HCM
|
14 | $ 13.18 | -2.04 % | $ 11.3 B | ||
|
Aptorum Group Limited
APM
|
0.91 | - | - | $ 5.72 M | ||
|
iBio
IBIO
|
1.36 | $ 0.83 | 3.01 % | $ 86.4 M | ||
|
Kodiak Sciences
KOD
|
38.1 | $ 97.05 | -0.87 % | $ 5.16 B | ||
|
Karyopharm Therapeutics
KPTI
|
4.12 | $ 0.02 | -56.5 % | $ 219 | ||
|
FSD Pharma
HUGE
|
1.31 | - | 5743.5 % | $ 69.7 M | ||
|
BioAtla
BCAB
|
3.53 | $ 1.74 | 0.64 % | $ 102 M | ||
|
Catalyst Pharmaceuticals
CPRX
|
24.9 | - | - | $ 3.85 B | ||
|
UroGen Pharma Ltd.
URGN
|
19.2 | $ 28.91 | -8.89 % | $ 1.39 B | ||
|
Catalyst Biosciences
CBIO
|
11.2 | $ 13.01 | 0.74 % | $ 1.16 B | ||
|
ARCA biopharma
ABIO
|
28.8 | - | 1052.0 % | $ 415 M | ||
|
ADiTx Therapeutics
ADTX
|
0.98 | - | - | $ 374 | ||
|
Aeterna Zentaris
AEZS
|
5.72 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
13 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | ||
|
AIkido Pharma
AIKI
|
3.17 | - | 1.93 % | $ 17.4 M | ||
|
Aileron Therapeutics
ALRN
|
2.13 | - | 10.36 % | $ 9.8 M | ||
|
AlloVir
ALVR
|
9.78 | - | 4.14 % | $ 49.1 M | ||
|
Apellis Pharmaceuticals
APLS
|
22 | - | - | $ 5.18 B | ||
|
Athira Pharma
ATHA
|
0.42 | - | - | $ 269 M | ||
|
AVROBIO
AVRO
|
1.27 | - | 1083.1 % | $ 745 M | ||
|
AstraZeneca PLC
AZN
|
74.2 | - | - | $ 96.9 B | ||
|
Brainstorm Cell Therapeutics
BCLI
|
1.26 | - | -2.5 % | $ 5.88 M | ||
|
BeiGene, Ltd.
BGNE
|
185 | - | 0.49 % | $ 251 B | ||
|
EyePoint Pharmaceuticals
EYPT
|
15.7 | $ 0.23 | -12.11 % | $ 16.8 K | ||
|
Bio-Path Holdings
BPTH
|
3.23 | - | - | $ 100 K | ||
|
Cara Therapeutics
CARA
|
1 | - | -3.03 % | $ 260 M | ||
|
ChromaDex Corporation
CDXC
|
5.67 | - | -0.88 % | $ 598 M | ||
|
Caladrius Biosciences
CLBS
|
0.43 | - | -16.75 % | $ 25.8 M | ||
|
Cyclacel Pharmaceuticals
CYCC
|
0.25 | - | -5.98 % | $ 34.1 M | ||
|
Diffusion Pharmaceuticals
DFFN
|
4.4 | - | 11.68 % | $ 8.97 M | ||
|
Eloxx Pharmaceuticals
ELOX
|
11 | - | -5.68 % | $ 8.28 M | ||
|
Enochian Biosciences
ENOB
|
0.7 | - | - | $ 40.5 M |